Status:
UNKNOWN
Supervised Resistance TRaining amONG Women at Risk of Breast Cancer Related Lymphedema
Lead Sponsor:
Pontificia Universidad Catolica de Chile
Collaborating Sponsors:
Universidad de Granada
National Fund for Research and Development in Health, Chile
Conditions:
Breast Cancer
Physical Activity
Eligibility:
FEMALE
18-70 years
Phase:
NA
Brief Summary
Breast cancer (BC) is the most common neoplasm in Chile, and its medical treatment leads to high survival. One-third of survivors will develop BC-related lymphedema. Lymphedema is a chronic condition ...
Eligibility Criteria
Inclusion
- Newly diagnosed with stage I-III breast cancer, histologically confirmed.
- Patients scheduled to receive adjuvant post-operative chemotherapy.
- Partial or total mastectomy with axillary node dissection.
- Partial or total mastectomy with sentinel node dissection with body mass index between 30.0 and 39.9 kg/m2.
- Approval of their treating physician to participate in sub-maximal physiological fitness testing and a low to moderate progressive resistance exercise program.
Exclusion
- Inter-limb volume difference greater than 200 ml or 10%.
- Previous antineoplastic treatment (chemotherapy, radiotherapy, or endocrine therapy).
- Breast cancer stage IV
- Unable to participate in an exercise program related to other medical problems.
- Be identified as vigorous exercise behavior related to American College of Sports Medicine recommendations.
- Body mass index lower than 18.5 kg/m2 or greater than 40 kg/m2.
- Pregnancy.
- Fluency and understanding of the Spanish language.
Key Trial Info
Start Date :
December 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT04821609
Start Date
December 1 2021
End Date
June 1 2023
Last Update
January 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karol Ramírez
Puente Alto, CO, Chile